1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
enVVeno Medical Corporation

enVVeno Medical Corporation

NVNOW
enVVeno Medical CorporationUS flagNASDAQ Capital Market
enVVeno Medical Corporation
NVNOW
(NASDAQ Capital Market)

Recent

price

0.01

P/E

ratio

-0.0033175355450236967

div

yld

- -

ROIC.AI

Capital Structure

•

in mil. unless spec.
Working Capital

•

in mil. unless spec.
Growth Rates

•

in mil. unless spec.
Quarterly Revenue

•

in mil. unless spec.
Quarterly Earnings Per Share

•

in mil. unless spec.
Quarterly Dividends Per Share

•

in mil. unless spec.
Similar Companies
Business
enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.